Sunresin New Materials Co.,Ltd (300487.SZ)
Xi'an, CN
Sunresin New Materials Co.,Ltd, a Chinese company, specializes in the research, development, production, and sale of advanced adsorption and separation materials, along with integrated exchange separation system devices. Its extensive product portfolio features a wide array of specialized resins, including adsorbent, catalyst, chelating, powder, and various strong and weak acid cation/anion ion exchange types, as well as mixed bed resins. The company also provides chromatographic media, enzyme carriers, and essential products for solid-phase peptide synthesis. Furthermore, Sunresin offers "Sepsolut," a comprehensive ion exchange and adsorbent system and solution. These versatile products are crucial for numerous sectors such as food and beverage, biopharmaceuticals and life sciences, botanical extraction, municipal and industrial water purification, chemical processing, hydrometallurgy and mining, and wastewater treatment and recycling. Established in 2001, Sunresin New Materials Co.,Ltd maintains its headquarters in Xi'an, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.90% | -1.58% | -5.90% | -19.70% | +12.74% | -2.85% | +32.84% | -3.99% | +86.42% | +599.18% | +1,478.68% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 5 | -1 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+9.1% ★ Q1'26: +5.2% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+14.2% ★ Q1'26: -5.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+20.5% Q1'26: +31.0% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+39.2% ★ Q1'26: +36.8% (vs Q1'25)
-
ROIC Chemicals: +3.4%+41.6% ★ Q1'26: +32.3% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-0.2% ★ Q1'26: -0.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.42× ★ Q1'26: 0.64× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 4 EPS Ana. |
Dec 2027 7 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
295.37M
est: 339.00M (-12.9%)
|
332.41M
est: 419.00M (-20.7%)
|
444.24M
est: 521.00M (-14.7%)
|
631.99M
est: 692.03M (-8.7%)
|
1.01B
est: 1.01B (0.0%)
|
922.63M
est: 871.73M (+5.8%)
|
1.19B
est: 1.20B (-0.8%)
|
1.92B
est: 1.92B (-0.1%)
|
2.49B
est: 2.78B (-10.3%)
|
2.55B
est: 2.63B (-2.9%)
|
2.79B
est: 2.84B (-2.0%)
|
3.45B
3.22B – 3.81B
+21.1% YoY
|
4.17B
3.53B – 4.99B
+20.9% YoY
|
5.01B
4.87B – 5.15B
+20.4% YoY
|
| EBITDA |
61.39M
est: 122.03M (-49.7%)
|
69.13M
est: 150.83M (-54.2%)
|
108.54M
est: 187.54M (-42.1%)
|
166.90M
est: 249.11M (-33.0%)
|
315.00M
est: 364.29M (-13.5%)
|
334.80M
est: 313.80M (+6.7%)
|
429.39M
est: 433.61M (-1.0%)
|
611.00M
est: 691.57M (-11.6%)
|
942.53M
est: 1.46B (-35.3%)
|
972.31M
est: 1.38B (-29.6%)
|
1.21B
est: 1.49B (-18.9%)
|
1.81B
1.69B – 2.00B
+21.1% YoY
|
2.19B
1.85B – 2.62B
+20.9% YoY
|
2.63B
2.56B – 2.71B
+20.4% YoY
|
| EBIT |
52.23M
est: 99.23M (-47.4%)
|
58.14M
est: 122.65M (-52.6%)
|
88.96M
est: 152.50M (-41.7%)
|
145.48M
est: 202.56M (-28.2%)
|
282.22M
est: 296.22M (-4.7%)
|
244.69M
est: 255.16M (-4.1%)
|
331.86M
est: 352.59M (-5.9%)
|
506.39M
est: 562.35M (-10.0%)
|
814.32M
est: 1.42B (-42.6%)
|
842.06M
est: 1.34B (-37.4%)
|
1.09B
est: 1.45B (-25.0%)
|
1.76B
1.65B – 1.95B
+21.1% YoY
|
2.13B
1.80B – 2.55B
+20.9% YoY
|
2.56B
2.49B – 2.63B
+20.4% YoY
|
| Net Income |
50.85M
est: 59.59M (-14.7%)
|
61.70M
est: 61.40M (+0.5%)
|
93.19M
est: 76.75M (+21.4%)
|
143.23M
est: 148.98M (-3.9%)
|
251.29M
est: 277.65M (-9.5%)
|
202.05M
est: 322.80M (-37.4%)
|
310.86M
est: 326.18M (-4.7%)
|
537.70M
est: 534.55M (+0.6%)
|
717.03M
est: 775.11M (-7.5%)
|
787.24M
est: 827.69M (-4.9%)
|
897.11M
est: 885.89M (+1.3%)
|
1.12B
1.11B – 1.15B
+26.0% YoY
|
1.40B
1.39B – 1.40B
+25.3% YoY
|
1.65B
1.39B – 1.92B
+18.2% YoY
|
| SGA |
50.66M
est: 31.20M (+62.3%)
|
59.41M
est: 38.57M (+54.0%)
|
54.15M
est: 47.96M (+12.9%)
|
70.38M
est: 63.70M (+10.5%)
|
113.31M
est: 93.15M (+21.6%)
|
106.38M
est: 80.24M (+32.6%)
|
109.76M
est: 110.88M (-1.0%)
|
176.95M
est: 176.84M (+0.1%)
|
196.88M
est: 210.37M (-6.4%)
|
208.98M
est: 199.29M (+4.9%)
|
94.64M
est: 215.54M (-56.1%)
|
261.10M
243.79M – 288.51M
+21.1% YoY
|
315.66M
267.37M – 378.40M
+20.9% YoY
|
379.92M
369.45M – 390.39M
+20.4% YoY
|
| EPS |
0.13
est: 0.12 (+10.8%)
|
0.14
est: 0.12 (+15.8%)
|
0.20
est: 0.15 (+32.4%)
|
0.31
est: 0.29 (+5.7%)
|
0.55
est: 0.55 (+0.6%)
|
0.43
est: 0.64 (-32.3%)
|
0.64
est: 0.64 (-0.3%)
|
1.08
est: 1.05 (+2.6%)
|
1.43
est: 1.54 (-7.2%)
|
1.56
est: 1.61 (-3.1%)
|
1.77
est: 1.81 (-2.0%)
|
2.23
2.20 – 2.26
+23.4% YoY
|
2.76
2.75 – 2.77
+23.9% YoY
|
3.30
2.75 – 3.78
+19.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | VanEck ChiNext ETF CNXT | 0.32% | 383.0K | 0.65% |
| 2 | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS | 0.21% | 75.7K | 0.65% |
| 3 | JPMorgan ETFs (Ireland) ICAV - China A Research Enhanced Index Equity Active UCITS ETF JREC.L | 0.08% | 17.3K | 0.40% |
| 4 | JPMorgan ActiveBuilders Emerging Markets Equity ETF JEMA | 0.06% | 1.02M | 0.33% |
| 5 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.05% | 23.6K | 0.54% |
| 6 | KraneShares ICBCCS S&P China 500 Index UCITS ETF CHIN.L | 0.05% | 35.8K | 0.55% |
| 7 | State Street SPDR S&P China ETF GXC | 0.04% | 161.7K | 0.59% |
| 8 | Franklin FTSE China ETF FLCH | 0.03% | 78.8K | 0.19% |
| 9 | Franklin FTSE China UCITS ETF FLXC.L | 0.02% | 332.7K | 0.19% |
| 10 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.02% | 340.0K | 0.58% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Fumin Guo | Deputy General Manager | — | male |
| Li Liu | Accounting Supervisor | — | — |
| Risheng Wang | Deputy General Manager | — | male |
| Weijun Wei | Deputy GM & Non-Independent Director | — | male |
| Xiaojun Tian | Deputy GM & Non-Independent Director | — | male |
| Xiaokang Kou | GM & Non-Independent Director | — | male |
| Yang Yu | Board Secretary & Deputy GM | — | male |
| Yuan An | Chief Financial Officer & Non-Independent Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300487.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
